8-K: Peraso Secures $1.1M from Warrant Exercise, Issues New Warrants

Peraso Inc. announced it will receive approximately $1.1 million in gross proceeds from the immediate exercise of existing Series C warrants at a reduced price, in exchange for issuing new Series E warrants.

Summary

• Peraso Inc. entered into an inducement offer letter agreement with a holder of existing Series C warrants.
• The holder agreed to exercise 952,380 Series C warrants for cash at a reduced exercise price of $1.18 per share, down from their original exercise price of $1.61.
• This transaction is expected to generate approximately $1.1 million in gross proceeds for Peraso.
• In consideration for the exercise, Peraso will issue new Series E common stock purchase warrants to purchase an aggregate of 952,380 shares of Common Stock.
• The new Series E warrants have an exercise price of $1.25 per share and a term of 5.5 years from their initial exercise date, which is six months after issuance.
• Ladenburg Thalmann & Co. Inc. acted as the exclusive placement agent, receiving a cash fee equal to 9% of the gross proceeds and warrants to purchase up to 7% of the aggregate number of shares issued to the holder.
• The net proceeds from the exercise of the existing warrants are intended for working capital and general corporate purposes.
• Peraso has agreed to file a registration statement for the resale of the new Series E warrant shares within 30 calendar days of September 11, 2025.

Sentiment

Score: 4

Explanation: While the company secured immediate cash, it came at the cost of a reduced exercise price for existing warrants and the issuance of new warrants, leading to potential future dilution and significant placement agent fees. The terms suggest a need for capital that required concessions.

Positives

• Secured approximately $1.1 million in gross proceeds, providing immediate cash flow for working capital and general corporate purposes.
• The new Series E warrants are fixed-priced at $1.25 per share and do not contain price reset or anti-dilution provisions, which can be favorable for existing shareholders by limiting future dilution from these specific warrants.

Negatives

• Existing Series C warrants were exercised at a reduced price of $1.18 per share, a significant concession from their original exercise price of $1.61, indicating a need to incentivize the holder.
• The issuance of new Series E warrants and Placement Agent Warrants will lead to potential future dilution for existing shareholders upon their exercise.
• The company incurred placement agent fees of 9% of gross proceeds and agreed to reimburse up to $45,000 in expenses, reducing the net capital raised.
• Restrictions are placed on the company's ability to issue new equity or effect Variable Rate Transactions for certain periods following the agreement.
• The holder of the new warrants is subject to a 'leak-out' provision, allowing them to sell up to 20% of daily trading volume for 15 days, which could put downward pressure on the stock price, unless the trading price is at or above $1.50.

Risks

• Potential future dilution for existing shareholders from the exercise of the new Series E warrants and Placement Agent Warrants.
• The new warrants and underlying shares are not registered under the Securities Act, and their resale will require an effective registration statement or an applicable exemption, which could affect liquidity for holders.
• Market conditions and other factors could cause actual events or results to differ materially from current expectations, as noted in the forward-looking statements disclaimer.
• The 'leak-out' provision for the holder could create selling pressure on the stock in the short term.

Future Outlook

The company intends to use the net proceeds from the warrant exercise for working capital and general corporate purposes. It has also committed to filing a registration statement for the resale of the new Series E warrant shares within 30 calendar days and to use commercially reasonable efforts to make it effective within 60 to 90 days.

Management Comments

• Peraso Inc., a pioneer in mmWave wireless technology solutions, announced today the entry into a definitive agreement for the immediate exercise of certain outstanding Series C warrants.

Industry Context

Peraso Inc. operates in the high-performance 60 GHz unlicensed and 5G mmWave wireless technology sector, providing chipsets, modules, software, and IP. Its solutions target applications such as fixed wireless access, military, immersive video, and factory automation, and focus on Accelerating Data Intelligence and Multi-Access Edge Computing. This capital raise provides additional working capital to support operations in these specialized and evolving technology markets.

Stakeholder Impact

• Shareholders: Potential dilution from the issuance and future exercise of new Series E warrants and Placement Agent Warrants. The reduced exercise price for existing warrants also implies a less favorable outcome for existing shareholders compared to the original terms.
• Company: Receives immediate cash for working capital and general corporate purposes, improving liquidity.
• Warrant Holders (Series C): Benefited from a reduced exercise price, making their warrants more valuable and encouraging immediate exercise.
• Placement Agent (Ladenburg Thalmann & Co. Inc.): Earned a 9% cash fee and received Placement Agent Warrants, indicating a significant financial benefit.

Next Steps

• Closing of the transactions contemplated by the Inducement Letter is expected on or about September 12, 2025.
• The company will file a registration statement on Form S-3 for the resale of the New Warrant Shares within 30 calendar days of September 11, 2025.
• The company will use commercially reasonable efforts to cause the resale registration statement to become effective within 60 calendar days (or 90 days if reviewed by the SEC).
• The company will keep the resale registration statement effective until the holder no longer owns New Warrants/Shares or the Delegend Date.
• The holder will furnish a completed Selling Stockholder Questionnaire within seven calendar days of September 11, 2025.

Key Dates

Recommendation

The immediate capital infusion of $1.1 million is a positive for Peraso's working capital. However, the terms of the deal, including the reduced exercise price for existing warrants and the issuance of new warrants with a lower exercise price and significant fees to the placement agent, suggest a company in need of capital making concessions. The potential for future dilution from the new warrants and the 'leak-out' provision for the holder could create downward pressure on the stock. Given the mixed signals of a capital raise at a discounted rate and future dilution, a 'hold' recommendation is appropriate until further clarity on the company's operational performance and strategic execution emerges.

Keywords

Peraso Inc., PRSO, Warrants, Equity Financing, Capital Raise, SEC Filing, 8-K, mmWave, Wireless Technology, Fixed Wireless Access, Semiconductors